IP Library Granted Patent US 7,258,693
Granted Patent B2
US 7,258,693 · App. 10/420,535 · Granted Aug 21, 2007

Device and method for variable speed lancet

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,258,693
App. No.
10/420,535
Granted
Aug 21, 2007
Kind
B2
Abstract

A method of penetrating tissue is provided. The method comprises using a lancet driver to advance a lancet into the tissue; advancing the lancet at a first desired velocity in a first layer of tissue; advancing the lancet at a second desired velocity in a second layer of tissue; and advancing the lancet at a third desired velocity in a third layer of tissue. In one embodiment, the method may including using a processor having logic for controlling velocity of the lancet in each layer of tissue.

Claims (39)

1. A method of penetrating tissue comprising:

using a lancet driver to advance a lancet into said tissue;

advancing said lancet at a first desired velocity in a first layer of tissue;

advancing said lancet at a second desired velocity in a second layer of tissue;

advancing said lancet at a third desired velocity in a third layer of tissue; and

creating a wound in the tissue; wherein at least two of the first, the second, the third velocity being different; and wherein the first, the second and the third layer are different tissue layer.

2. The method of claim 1 further comprising using a processor having logic for controlling velocity of the lancet in each layer of tissue.

3. The method of claim 2 wherein said lancet achieves a lancet velocity between about 4 to 10 m/s while in at least one of the layers of tissue.

4. The method of claim 2 wherein said lancet achieves a penetration depth, as measured from a surface of the tissue, of between about 0.5 to about 2.0 mm.

5. The method of claim 2 wherein said second desired velocity is sufficient to minimize nerve stimulation while maintaining cutting efficiency.

6. The method of claim 2 wherein said second velocity is the same as the first velocity.

7. The method of claim 2 wherein said first velocity is at least partially determined based on hydration of the stratum corneum.

8. The method of claim 2 wherein said second velocity is at least partially determined based on hydration of the stratum corneum.

9. The method of claim 2 wherein a four edge algorithm is used to control lancet velocity.

10. The method of claim 2 wherein there are at least 30 different decision points to change lancet velocity during penetration.

11. The method of claim 2 wherein there are at least 30 different decision points to change lancet velocity prior to the lancet reaching a stopped position in the tissue.

12. The method of claim 2 further comprising using a first detection algorithm on a lancet inbound phase and a second detection algorithm on a lancet outbound phase.

13. The method of claim 2 controlling lancet velocity to within 1% at a speed of 5 m/s.

14. The method of claim 2 lancing according to regional velocity profiles based on variation of cell type.

15. The method of claim 2 lancing according to regional velocity, said velocity base on changes of regional cell types and the resistance they provide.

16. The method of claim 2 lancing according to regional velocity profiles based on location to pain sensors.

17. The method of claim 2 wherein position and velocity are determined based on cell population and distribution in the different zones of tissue.

18. The method of claim 2 wherein said lancet has a maximum velocity through a stratum corneum, has a velocity in the epidermis sufficient to reduce shock waves to pain sensor in dermis, and a velocity through in the dermis sufficient for efficient cutting of blood vessels without stimulating pain sensors.

19. The method of claim 1 wherein said penetrating member achieves a penetrating member velocity between about 4 to 10 m/s while in at least one of the layers of tissue.

20. The method of claim 1 wherein said penetrating member achieves a penetration depth, as measured from a surface of the tissue, of between about 0.5 to about 2.0 mm.

21. The method of claim 1 wherein said penetrating member is sufficient to minimize nerve stimulation while maintaining cutting efficiency.

22. The method of claim 1 wherein said second velocity is the same as the first velocity.

23. The method of claim 1 wherein said first velocity is at least partially determined based on hydration of the stratum corneum.

24. The method of claim 1 wherein said second velocity is at least partially determined based on hydration of the stratum corneum.

25. The method of claim 1 wherein a four edge algorithm is used to control penetrating member velocity.

26. The method of claim 1 wherein there are at least 30 different decision points to change penetrating member velocity during penetration.

27. The method of claim 1 wherein there are at least 30 different decision points to change penetrating member velocity prior to reaching.

28. The method of claim 1 further comprising using a first detection algorithm on a penetrating member inbound phase and a second detection algorithm on a penetrating member outbound phase.

29. The method of claim 1 controlling penetrating member velocity to within 1% at a speed of 5 m/s.

30. The method of claim 1 lancing according to regional velocity profiles based on variation of cell type.

31. The method of claim 1 lancing according to regional velocity, said velocity based on changes of regional cell types and the resistance they provide.

32. The method of claim 1 lancing according to regional velocity profiles based on location to pain sensors.

33. The method of claim 1 wherein position and velocity are determined based on cell population and distribution in the different zones of tissue.

34. The method of claim 1 wherein said penetrating member has a maximum velocity through a stratum corneum, has a velocity in the epidermis sufficient to reduce shock waves to pain sensor in dermis, and a velocity through in the dermis sufficient for efficient cutting of blood vessels without stimulating pain sensors.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 23, 2012
From: PELIKAN TECHNOLOGIES, INC.
To: SANOFI-AVENTIS DEUTSCHLAND GMBH
Reel/Frame 028259/0634 →
RELEASE OF SECURITY INTEREST Recorded Mar 2, 2010
From: GENERAL ELECTRIC CAPITAL CORPORATION
To: PELIKAN TECHNOLOGIES, INC.
Reel/Frame 024016/0492 →
SECURITY AGREEMENT Recorded Dec 18, 2008
From: PELIKAN TECHNOLOGIES, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION
Reel/Frame 021998/0381 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 29, 2003
From: FREEMAN, DOMINIQUE M.; BOECKER, DIRK
To: PELIKAN TECHNOLOGIES, INC.
Reel/Frame 013930/0259 →